Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Operating Activities
Net income		$ 97	$ 107
Adjustments to reconcile net income to net cash provided by operating activities:
Deferred income taxes, net		5	44
Depreciation and amortization		129	125
Amortization of nuclear fuel		9	10
Other adjustments		(7)	(8)
Changes in certain assets and liabilities:
Receivables		91	18
Receivables - affiliated and related party		1	8
Inventories		0	3
Prepayments		5	13
Regulatory assets		56	(66)
Regulatory liabilities		(122)	56
Accounts payable		(87)	22
Accounts payable - affiliated and related party		11	(3)
Taxes accrued		(165)	(156)
Interest accrued		(7)	(5)
Pension and other postretirement benefits		0	(4)
Other assets and liabilities		56	(126)
Net cash provided by operating activities		72	38
Investing Activities
Property additions and construction expenditures		(283)	(211)
Proceeds from investments and sales of assets		(8)	2
Purchase of investments		(4)	(1)
Other		1	0
Net cash used in investing activities		(294)	(210)
Financing Activities
Dividend to parent		(50)	(110)
Short-term borrowings, net		28	52
Short-term borrowings - affiliated, net		235	231
Other		1	(1)
Net cash provided by financing activities		214	172
Net decrease in cash, restricted cash and equivalents		(8)	0
Cash, restricted cash and equivalents at beginning of period	[1]	11	54
Cash, restricted cash and equivalents at end of period	[1]	3	54
Significant noncash investing and financing activities:
Accrued construction expenditures	[2]	$ 54	$ 75

[1] Includes $24 million of restricted cash at both March 31, 2022 and December 31, 2021, recorded within other current assets on the Consolidated Balance Sheets. At March 31, 2023 and December 31, 2022 there were no restricted cash and equivalent balances.

[2] See Note 10 for noncash investing activities related to the transfer of property associated with the settlement of litigation.